510(k) Report

510(k) · Cleared

Cleared

Flocap

K133540510(k) TraditionalCleared Mar 28, 2014130-day reviewClass II21 CFR 868.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Maxtec, Inc. · CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase

Cleared on Mar 28, 2014 as substantially equivalent to K021576 (Mercury Medical, 2002) after a 130-day review. Its family tree reaches back 2 generations to 1989. 1 later device descends from it.

Decided
Mar 28, 2014
Review
130 days
Class
Class II
Product code
CCK
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K894053 (1989). 1 later device descends from it, 1 citing it directly.

  1. Root · 2 generations backK894053 2ND Modification of Fef (TM) End-Tidal CO2 DetectorFenem, Inc. · 1989
  2. 1 generation backK021576 Mercury Medical STATCO2 End Tidal CO2 Detector, Model 10-55370Mercury Medical · 2002
  3. This deviceK133540 FlocapMaxtec, Inc. · 2014
  4. Descendant · cites it directly · 0 of its ownK261633 VisuBreathAffirm Medical Technologies II, LLC · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K261633VisuBreathAffirm Medical Technologies II, LLC · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K8940532ND Modification of Fef (TM) End-Tidal CO2 DetectorFenem, Inc.1989—
−1K021576Mercury Medical STATCO2 End Tidal CO2 Detector, Model 10-55370Mercury Medical2002—
0 (this device)K133540FlocapMaxtec, Inc.2014—
+1K261633VisuBreathAffirm Medical Technologies II, LLC2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K133540, 1989–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CCK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CCK device

  1. #1 K253030 Capnostream™35 Portable Respiratory Monitor…score 15.8 · 16 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021576Mercury Medical STATCO2 End Tidal CO2 Detector, Model 10-55370
Summary page 1
…: FLOCAP Common/Usual Name: ' CO; detector Classification Name: Carbon dioxide gas analyzer CCK - 21 CFR 868.1400 Class 2 Predicate Devices: Mercury Medical - StatCO, — K021576 Device Description The proposed FLOCAP is comprised of several components: * Housing with standard 15 mm / 22 mm fittings 1o co…
Mercury Medical2002—

Also cleared against K021576: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K261633VisuBreathAffirm Medical Technologies II, LLC20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 13.3 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K261633 (Affirm Medical Technologies II, LLC, 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K021576.

How does its category compare?

All CCK devices

CCK Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · CCK

3in 2025

2007: 52008: 32009: 32010: 32011: 22012: 72013: 42014: 92015: 52016: 22017: 52018: 62019: 72020: 42021: 42022: 32023: 42024: 32025: 32026 (partial year): 3
2007high 9 (2014) · low 2 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CCK

169in 2025

2007: 56 days median2008: 248 days median2009: 101 days median2010: 125 days median2012: 150 days median2013: 132 days median2014: 166 days median2015: 105 days median2017: 134 days median2018: 296 days median2019: 261 days median2020: 188 days median2021: 227 days median2022: 226 days median2023: 555 days median2024: 592 days median2025: 169 days median2026 (partial year): 224 days median
2007high 592 (2024) · low 56 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CCK

1in 2022

2008: 12009: 192010: 42011: 142012: 32013: 2, 1 Class I2015: 12018: 52019: 7, 7 Class I2020: 12022: 1
2007high 19 (2009) · low 0 (2007)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · CCK

1,259in 2025

2007: 72008: 202009: 212010: 122011: 182012: 132013: 282014: 512015: 1142016: 882017: 582018: 632019: 1412020: 2,3022021: 2,2722022: 2,4752023: 1,6372024: 1,2162025: 1,259
2007high 2,475 (2022) · low 7 (2007)2025

MAUDE reports naming product code CCK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200755607
20083248120
200931011921
20103125412
20112—1418
20127150313
201341322 (1)28
20149166051
201551051114
20162—088
20175134058
20186296563
201972617 (7)141
2020418812,302
2021422702,272
2022322612,475
2023455501,637
2024359201,216
2025316901,259
202632240—

What is it indicated for?

The FLOCAP is to provide a semi-quantitative visualization of the CO2 in the patient airway. It is an adjunct in patient assessment, to be used in conjunction with other methods to determine clinical signs and symptoms by or on the order of a physician.

The FLOCAP has a visual indicator to visually detect the end of exhalation.

For use up to 24 hours.

For patients greater than 15 kg (33 lbs.)

Environment of use — hospital, sub-acute, pre-hospital, transport

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K133540: Flocap.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K133540

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026